Detectably labeled macrophage scavenger receptor antagonists useful for the diagnosis and monitoring of various cardiovascular diseases including but not limited to atherosclerosis, vulnerable plaque, coronary artery disease, renal disease, thrombosis, transient ischemia due to clotting, stroke, myocardial infarction, organ transplant, organ failure and hypercholesterolemia.

 
Web www.patentalert.com

< Targeting of molecules to large vessel endothelium using EPCR

< Implantable intravascular device for defibrillation and/or pacing

> Methods and reagents for the detection of antibodies to adenovirus

> Therapeutic agents

~ 00226